Related PDB-101 Resources Browse Drug Action Browse You and Your Health Browse Diabetes Browse Biomolecular Structural Biology References 6LN2: Wu F, Yang L, Hang K, Laursen M, Wu L, Han GW, Ren Q, Roed NK, Lin G, Hanson MA, Jiang H, Wang MW, Reedtz-Runge S, Song G, Stevens RC
While GLP-1s are not FDA-approved to treat hormone imbalance or infertility, the weight loss they promote can actually help improve reproductive health
Novo Nordisk reports up to 13.8% weight loss in people with obesity receiving semaglutide in phase 2 trial
[DOI] [PMC free article] [PubMed] [Google Scholar] 159.Charidemou E., Ashmore T., Li X., McNally B.D., West J.A., Liggi S., Harvey M., Orford E., Griffin J.L
That's not a benefit
Lets put a stop to these agonizing, piecemeal efforts to formulate a coherent policy on GLP-1s